Alseres Pharmaceuticals, Inc. · Hopkinton, MA United States · (NASDAQ (CM): ALSE)
Company Description
More Companies in: Hopkinton, Massachusetts
More Companies in These Related Industries: Pharmaceutical Preparation Mfg
View Alseres Pharmaceuticals, Inc. Locations On A US Map
This link will open in a new window
This link will open in a new window Unlike most people, the folks at Alseres Pharmaceuticals (formerly Boston Life Sciences) want to get on your nerves. The biotechnology company is developing therapies and diagnostics related to nervous system conditions, such as spinal cord injury, Parkinson's disease, and attention deficit hyperactivity disorder (ADHD). Its lead candidate is Altropane, a molecular imaging agent for diagnosing Parkinson's disease and ADHD. Another candidate, Cethrin, aims to repair nerve damage caused by spinal cord injury; Alseres licensed Cethrin from Canadian firm BioAxone Therapeutic in 2006. To read the full description, subscribe now.
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!
Alseres Pharmaceuticals, Inc. Reports
No subscription, no problem.
Download presentation-ready reports for this company now.
Download presentation-ready reports for this company now.
From company profiles to the competitive landscape, Hoover’s offers immediate access to individual reports.
Key Alseres Pharmaceuticals, Inc. Financials
| Company Type | Public - NASDAQ (CM): ALSE Headquarters |
| Fiscal Year-End | December |
| 2008 Employees | 27 |
Alseres Pharmaceuticals, Inc. Executives
19 executives listed for Alseres Pharmaceuticals, Inc.'s Hopkinton, MA location.
| Title | Name & Bio | Contact |
| Chairman and CEO | Peter Savas | |
| President and COO | Mark Pykett | |
| EVP Finance and Administration, CFO, and In-House Counsel | Kenneth Rice |
Competition
Competitive Landscape for Alseres Pharmaceuticals, Inc.
Demand often depends on the income of consumers or the profitability of business customers, because many technology products and services are expensive. The profitability of individual companies is driven by their ability to develop and market new products. Large companies often have advantages in access to capital and marketing. Small companies can compete successfully if they have expertise in a particular field of knowledge. The industry is capital-intensive: average annual revenue per worker is nearly $300,000. To read the full description, subscribe now.Top Alseres Pharmaceuticals, Inc. Competitors
Call Now at 866-464-3202 or Click here for a Free Hoover's Trial!